A University of Bristol spin-out firm has raised £415,000 to accelerate trials in liver disease. Rosa Biotech will use the finding to speed up its pioneering bio-sensing technology. The company – spun out from the University of Bristol in 2019 – is initially targeting the early identification of non-alcoholic fatty liver disease (NAFL) which, if … Continue reading University spin-out nets £415k